Wild-type HFE protein normalizes transferrin iron accumulation in macrophages from subjects with hereditary hemochromatosis

被引:117
作者
Montosi, G
Paglia, P
Garuti, C
Guzman, CA
Bastin, JM
Colombo, MP
Pietrangelo, A
机构
[1] Univ Modena, Dept Internal Med, Unit Study Disorders Iron Metab, I-41100 Modena, Italy
[2] Ist Nazl Tumori, Immunotherapy & Gene Therapy Unit, I-20133 Milan, Italy
[3] GBF, Natl Res Ctr Biotechnol, Div Microbiol, Braunschweig, Germany
[4] Univ Oxford, John Radcliffe Hosp, Inst Mol Med, Oxford OX3 9DU, England
关键词
D O I
10.1182/blood.V96.3.1125.015k19_1125_1129
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hereditary hemochromatosis (HC) is one of the most common single-gene hereditary diseases. A phenotypic hallmark of HC is low iron in reticuloendothelial cells in spite of body iron overload. Most patients with HC have the same mutation, a change of cysteine at position 282 to tyrosine (C282Y) in the HFE protein. The role of HFE in iron metabolism and the basis for the phenotypic abnormalities of HC are not understood. To clarify the role of HFE in the phenotypic expression of HC, we stud led monocytes-macrophages from subjects carrying the C282Y mutation in the HFE protein and clinically expressing HC and transfected them with wild-type HFE by using an attenuated Salmonella typhimurium strain as a gene carrier. The Salmonella system allowed us to deliver genes of interest specifically to monocytes-macrophages with high transduction efficiency. The accumulation of Fe-55 delivered by Fe-55-Tf was significantly lower in macrophages from patients with HC than from controls expressing wild-type HFE. Transfection of HC macrophages with the HFE gene resulted in a high level of expression of HFE protein at the cell surface, The accumulation of Fe-55 delivered by 55Fe-Tf was raised by 40% to 60%, and this was reflected by an increase in the Fe-55-ferritin pool within the HFE-transfected cells. These results suggest that the Iron-deficient phenotype of HC macrophages is a direct effect of the HFE mutation, and they demonstrate a role for HFE in the accumulation of iron in these cells. (C) 2000 by The American Society of Hematology.
引用
收藏
页码:1125 / 1129
页数:5
相关论文
共 27 条
[1]   Hemochromatosis: The genetic disorder of the twenty-first century [J].
Barton, JC ;
Bertoli, LF .
NATURE MEDICINE, 1996, 2 (04) :394-395
[2]   Kupffer cell staining by an HFE-specific monoclonal antibody: implications for hereditary haemochromatosis [J].
Bastin, JM ;
Jones, M ;
O'Callaghan, CA ;
Schimanski, L ;
Mason, DY ;
Townsend, ARM .
BRITISH JOURNAL OF HAEMATOLOGY, 1998, 103 (04) :931-941
[3]  
BJORNRASMUSSEN E, 1985, SCAND J HAEMATOL, V34, P308
[4]   Inappropriately high iron regulatory protein activity in monocytes of patients with genetic hemochromatosis [J].
Cairo, G ;
Recalcati, S ;
Montosi, G ;
Castrusini, E ;
Conte, D ;
Pietrangelo, A .
BLOOD, 1997, 89 (07) :2546-2553
[5]   Oral somatic transgene vaccination using attenuated S-typhimurium [J].
Darji, A ;
Guzman, CA ;
Gerstel, B ;
Wachholz, P ;
Timmis, KN ;
Wehland, J ;
Chakraborty, T ;
Weiss, S .
CELL, 1997, 91 (06) :765-775
[6]   Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter [J].
Donovan, A ;
Brownlie, A ;
Zhou, Y ;
Shepard, J ;
Pratt, SJ ;
Moynihan, J ;
Paw, BH ;
Drejer, A ;
Barut, B ;
Zapata, A ;
Law, TC ;
Brugnara, C ;
Kingsley, PD ;
Palis, J ;
Fleming, MD ;
Andrews, NC ;
Zon, LI .
NATURE, 2000, 403 (6771) :776-781
[7]   The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding [J].
Feder, JN ;
Penny, DM ;
Irrinki, A ;
Lee, VK ;
Lebrón, JA ;
Watson, N ;
Tsuchihashi, Z ;
Sigal, E ;
Bjorkman, PJ ;
Schatzman, RC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (04) :1472-1477
[8]   A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis [J].
Feder, JN ;
Gnirke, A ;
Thomas, W ;
Tsuchihashi, Z ;
Ruddy, DA ;
Basava, A ;
Dormishian, F ;
Domingo, R ;
Ellis, MC ;
Fullan, A ;
Hinton, LM ;
Jones, NL ;
Kimmel, BE ;
Kronmal, GS ;
Lauer, P ;
Lee, VK ;
Loeb, DB ;
Mapa, FA ;
McClelland, E ;
Meyer, NC ;
Mintier, GA ;
Moeller, N ;
Moore, T ;
Morikang, E ;
Prass, CE ;
Quintana, L ;
Starnes, SM ;
Schatzman, RC ;
Brunke, KJ ;
Drayna, DT ;
Risch, NJ ;
Bacon, BR ;
Wolff, RK .
NATURE GENETICS, 1996, 13 (04) :399-408
[9]   The hemochromatosis founder mutation in HLA-H disrupts beta(2)-microglobulin interaction and cell surface expression [J].
Feder, JN ;
Tsuchihashi, Z ;
Irrinki, A ;
Lee, VK ;
Mapa, FA ;
Morikang, E ;
Prass, CE ;
Starnes, SM ;
Wolff, RK ;
Parkkila, S ;
Sly, WS ;
Schatzman, RC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (22) :14025-14028
[10]  
FINCH CA, 1986, CLIN PHYSIOL BIOCH, V4, P5